| 臺大學術典藏 |
2021-08-21T23:59:49Z |
Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma
|
Gow, Chien Hung; MIN-SHU HSIEH; Liu, Yi Nan; Lee, Yi Hsuan; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-08-15T00:08:18Z |
Not All EGFR Exon 20 Insertions Are Created Equal
|
YEN-TING LIN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-08-15T00:08:17Z |
Real-world insights into patients with advanced NSCLC and MET alterations
|
Bittoni, Marisa; CHIH-HSIN YANG; JIN-YUAN SHIH; Peled, Nir; Smit, Egbert F.; Camidge, D. Ross; Arasada, Rajeswara Rao; Oksen, Dina; Boutmy, Emmanuelle; Stroh, Christopher; Johne, Andreas; Carbone, David P.; Paik, Paul K. |
| 臺大學術典藏 |
2021-08-15T00:07:58Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
BIN-CHI LIAO; Hsu, Wei Hsun; Lee, Jih Hsiang; Yang, Ching Yao; TZU-HSIU TSAI; WEI-YU LIAO; CHAO-CHI HO; Chia-Chi Lin; JIN-YUAN SHIH; CHONG-JEN YU; Soo, Ross A.; CHIH-HSIN YANG |
| 臺大學術典藏 |
2021-07-30T01:30:25Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Huang, Yen Lin; Chih-Hsin Yang, James; SHANG-GIN WU; WEI-YU LIAO; KANG-YI SU; SUNG-LIANG YU; CHONG-JEN YU; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-07-22T01:17:01Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
LI-TA KENG; MENG-RUI LEE; Chong-Jen Yu; Jann-Yuan Wang; Hung-Ling Huang; Hsu-Liang Chang; Chau-Chyun Sheu; Pin-Kuei Fu; Inn-Wen Chong; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-07-21T23:21:30Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
SHANG-GIN WU; WEI-YU LIAO; KANG-YI SU; SUNG-LIANG YU; Huang, Yen Lin; CHONG-JEN YU; Chih-Hsin Yang, James; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-07-21T23:21:17Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
MENG-RUI LEE; Huang, Hung Ling; LI-TA KENG; Chang, Hsu Liang; Sheu, Chau Chyun; Fu, Pin Kuei; JANN-YUAN WANG; Chong, Inn Wen; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-07-15T05:32:16Z |
Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning
|
Wang, You Wei; Chen, Chii Jen; Huang, Hsu Cheng; Wang, Teh Chen; HSIN-MING CHEN; JIN-YUAN SHIH; JIN-SHING CHEN; YU-SEN HUANG; YEUN-CHUNG CHANG; RUEY-FENG CHANG |
| 臺大學術典藏 |
2021-07-15T05:31:52Z |
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
|
Lin, Chia Yi; Huang, Kuo Yen; Lin, Yi Chun; Yang, Shuenn Chen; Chung, Wei Chia; YIH-LEONG CHANG; JIN-YUAN SHIH; CHAO-CHI HO; Lin, Chih An; Shih, Chih Chun; Chang, Ya Hsuan; Kao, Shih Han; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-07-15T05:31:52Z |
Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions
|
KAI-LUN YU; SHUN-MAO YANG; Ko, Huan Jang; Tsai, Hui Yu; JEN-CHANG KO; Lin, Ching Kai; CHAO-CHI HO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-21T11:40:32Z |
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
|
CHIA-LIN HSU; TZU-HSIU TSAI; CHUN-KAI HUANG; Yang, Ching Yao; WEI-YU LIAO; CHAO-CHI HO; SHENG-YUAN RUAN; Chen, Kuan Yu; JIN-YUAN SHIH; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-05-02T03:49:16Z |
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
|
Lin C.-C.;Huang Y.-K.;Cho C.-F.;Lin Y.-S.;Lo C.-C.;Kuo T.-T.;Tseng G.-C.;Cheng W.-C.;Chang W.-C.;Hsiao T.-H.;Lai L.-C.;Jin-Yuan Shih;Liu Y.-H.;Clifford Chao K.S.;Hsu J.L.;Lee P.-C.;Sun X.;Hung M.-C.;Sher Y.-P.; Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Lai L.-C.; JIN-YUAN SHIH; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P. |
| 臺大學術典藏 |
2021-05-02T03:49:15Z |
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life
|
Hsieh C.-C.;Ho C.-C.;Lin Z.-Z.;Yu C.-J.;Jow G.-M.;Huang F.-Y.;Jin-Yuan Shih;Hsiao F.-H.; Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; Yu C.-J.; Jow G.-M.; Huang F.-Y.; JIN-YUAN SHIH; Hsiao F.-H. |
| 臺大學術典藏 |
2021-05-02T03:49:15Z |
Detecting small pulmonary nodules with spiral ultrashort echo time sequences in 1.5?T MRI
|
Huang Y.-S.;Niisato E.;Su M.-Y.M.;Benkert T.;Hsu H.-H.;Jin-Yuan Shih;Chen J.-S.;Chang Y.-C.; Huang Y.-S.; Niisato E.; Su M.-Y.M.; Benkert T.; Hsu H.-H.; JIN-YUAN SHIH; Chen J.-S.; Chang Y.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:15Z |
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
|
Wu S.-G.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih; Wu S.-G.; Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Wu S.-G.;Chiang C.-L.;Liu C.-Y.;Wang C.-C.;Su P.-L.;Hsia T.-C.;Jin-Yuan Shih;Chang G.-C.; Wu S.-G.; Chiang C.-L.; Liu C.-Y.; Wang C.-C.; Su P.-L.; Hsia T.-C.; JIN-YUAN SHIH; Chang G.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
Does pemetrexed work in targetable, nonsquamous non-small-cell lung cancer? A narrative review
|
Jin-Yuan Shih;Inoue A.;Cheng R.;Varea R.;Kim S.-W.; JIN-YUAN SHIH; Inoue A.; Cheng R.; Varea R.; Kim S.-W. |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
Sustained partial response to afatinib in a patient with lung adenocarcinoma harboring HER2V659E mutation
|
Chang L.-K.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
Successful management of a ROS1-rearranged pulmonary pleomorphic carcinoma using serial tyrosine kinase inhibitors
|
Wu C.-W.;Yang C.-Y.;Chang Y.-L.;Jin-Yuan Shih; Wu C.-W.; Yang C.-Y.; Chang Y.-L.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
|
Nishio M.;Seto T.;Reck M.;Garon E.B.;Chiu C.-H.;Yoh K.;Imamura F.;Park K.;Jin-Yuan Shih;Visseren-Grul C.;Frimodt-Moller B.;Zimmermann A.;Homma G.;Enatsu S.;Nakagawa K.;Relay Study Investigators; Nishio M.; Seto T.; Reck M.; Garon E.B.; Chiu C.-H.; Yoh K.; Imamura F.; Park K.; JIN-YUAN SHIH; Visseren-Grul C.; Frimodt-Moller B.; Zimmermann A.; Homma G.; Enatsu S.; Nakagawa K.; RELAY Study Investigators |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-�eB Pathway
|
Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Wang H.-Y.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Wang H.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
Effect of �]-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
|
Chang C.-H.;Lee C.-H.;Ko J.-C.;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Jin-Yuan Shih;Yu C.-J.; Chang C.-H.; Lee C.-H.; Ko J.-C.; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
|
Lu S.; JIN-YUAN SHIH; Jang T.-W.; Liam C.-K.; Yu Y. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang G.-C.; Lam D.C.-L.; Tsai C.-M.; Chen Y.-M.; JIN-YUAN SHIH; Aggarwal S.; Wang S.; Kim S.-W.; Kim Y.-C.; Wahid I.; Li R.; Lim D.W.-T.; Sriuranpong V.; Chan R.T.-T.; Lorence R.M.; Carriere P.; Raabe C.; Cseh A.; Park K. |
| 臺大學術典藏 |
2021-05-02T03:49:11Z |
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel
|
Huang J.-W.; Kuo C.-H.; Kuo H.-C.; JIN-YUAN SHIH; Tsai T.-W.; Chang L.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:11Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; JIN-YUAN SHIH; Chang Y.-L.; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:10Z |
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
|
Hsu C.-L.; Tsai T.-H.; Huang C.-K.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Ruan S.-Y.; Chen K.-Y.; JIN-YUAN SHIH; Yang P.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:10Z |
Differences in Fatty Acid Oxidation between Nab-Paclitaxel- And Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics
|
Huang J.-W.; Kuo C.-H.; Kuo H.-C.; JIN-YUAN SHIH; Tsai T.-W.; Chang L.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:09Z |
Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer
|
Huang Y.-S.; Chen J.L.-Y.; Chen H.-M.; Yeh L.-H.; JIN-YUAN SHIH; Yen R.-F.; Chang Y.-C. |
| 臺大學術典藏 |
2021-04-21T23:30:40Z |
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel
|
Huang, Jhih Wei; CHING-HUA KUO; Kuo, Han Chun; JIN-YUAN SHIH; Tsai, Teng Wen; LIN-CHAU CHANG |
| 臺大學術典藏 |
2021-03-11T08:34:21Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-03-11T08:34:18Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen, Yueh Feng; MENG-RUI LEE; Yang, Ching Yao; JANN-YUAN WANG; JEN-CHUNG KO; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-01-18T09:12:07Z |
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
|
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Chiu, Chao Hua; Yoh, Kiyotaka; Imamura, Fumio; Park, Keunchil; JIN-YUAN SHIH; Visseren-Grul, Carla; Frimodt-Moller, Bente; Zimmermann, Annamaria; Homma, Gosuke; Enatsu, Sotaro; Nakagawa, Kazuhiko |
| 臺大學術典藏 |
2021-01-08T02:56:46Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Yen-Fu Chen; I-Chun Chen; Jui-Chen Cheng; SHENG-KAI LIANG; Shu-Yung Lin; Li-Ta Keng;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; LI-TA KENG; Kuei-Pin Chung; Hou-Tai Chang; Chia-Lin Hsu; Jih-Shuin Jerng; Hao-Chien Wang; Ping-Hung Kuo; Huey-Dong Wu; Jin-Yuan Shih; Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-13T06:34:14Z |
Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome
|
Jin-Yuan Shih;Yang S.-C.;Yu C.-J.;Wu H.-D.;Liaw Y.-S.;Wu R.;Yang P.-C.; JIN-YUAN SHIH; Yang S.-C.; Yu C.-J.; Wu H.-D.; Liaw Y.-S.; Wu R.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:14Z |
Echogenic floating spherules as a sonographic sign of cystic teratoma of mediastinum: Correlation with CT and pathologic findings
|
Wang H.-C.; JIN-YUAN SHIH; Jin-Yuan Shih;Wang H.-C.;Chang Y.-L.;Chang Y.-C.;Lee Y.-C.;Yang P.-C.; Chang Y.-L.; Chang Y.-C.; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:13Z |
Nontuberculous mycobacteria isolates: Clinical significance and disease spectrum
|
Wang H.-C.; Lee L.-N.; Hsueh P.-R.; JIN-YUAN SHIH; Jin-Yuan Shih;Hsueh P.-R.;Lee L.-N.;Wang H.-C.;Yang P.-C.;Kuo S.-H.;Luh K.-T.; Yang P.-C.; Kuo S.-H.; Luh K.-T. |
| 臺大學術典藏 |
2020-08-13T06:34:11Z |
New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas
|
Lee Y.-C.; JIN-YUAN SHIH; Wu C.-T.; Chang Y.-L.; Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:11Z |
Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells
|
Jin-Yuan Shih;Yang S.-C.;Hong T.-M.;Yuan A.;Chen J.J.W.;Yu C.-J.;Chang Y.-L.;Lee Y.-C.;Peck K.;Wu C.-W.;Yang P.-C.; JIN-YUAN SHIH; Yang S.-C.; Hong T.-M.; Yuan A.; Chen J.J.W.; Yu C.-J.; Chang Y.-L.; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Tumor-associated antigen L6 and the invasion of human lung cancer cells
|
Chu Y.-W.; Yang P.-C.; Wu C.-W.; Roffler S.R.; Kao Y.-R.;Jin-Yuan Shih;Wen W.-C.;Ko Y.-P.;Chen B.-M.;Chan Y.-L.;Chu Y.-W.;Yang P.-C.;Wu C.-W.;Roffler S.R.; Chan Y.-L.; Chen B.-M.; Ko Y.-P.; Wen W.-C.; JIN-YUAN SHIH; Kao Y.-R. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Collapsin response mediator protein-1: A novel invasion-suppressor gene
|
Lee Y.-C.G.; Yang S.-C.; Hong T.-M.; Huang C.-Y.F.; Yang P.-C.; JIN-YUAN SHIH; Jin-Yuan Shih;Lee Y.-C.G.;Yang S.-C.;Hong T.-M.;Huang C.-Y.F.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Tuberculous myositis: A rare but existing clinical entity
|
JIN-YUAN SHIH; Chang Y.L.; Yang P.C.; Luh K.T.; Hsueh P.R.; Lee L.N.; Wang J.Y.; Wang J.Y.;Lee L.N.;Hsueh P.R.;Jin-Yuan Shih;Chang Y.L.;Yang P.C.;Luh K.T. |
| 臺大學術典藏 |
2020-08-13T06:34:10Z |
Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure
|
Yang P.-C.; Yu C.-J.; Wu R.-M.; Wang H.-C.; JIN-YUAN SHIH; Jiang J.-R.; Jiang J.-R.;Jin-Yuan Shih;Wang H.-C.;Wu R.-M.;Yu C.-J.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:09Z |
Cyclooxygenase-2-Induces EP1- and HER-2/Neu-Dependent Vascular, Endothelial Growth Factor-C Up-Regulation: A Novel Mechanism of Lymphangiogenesis in Lung Adenocarcinoma
|
Su J.-L.;Jin-Yuan Shih;Yen M.-L.;Jeng Y.-M.;Chang C.-C.;Hsieh C.-Y.;Wei L.-H.;Yang P.-C.;Kuo M.-L.; Su J.-L.; JIN-YUAN SHIH; Yen M.-L.; Jeng Y.-M.; Chang C.-C.; Hsieh C.-Y.; Wei L.-H.; Yang P.-C.; Kuo M.-L. |
| 臺大學術典藏 |
2020-08-13T06:34:08Z |
Sialyl Lewis antigens: Association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer
|
Yu C.-J.;Jin-Yuan Shih;Lee Y.-C.;Shun C.-T.;Yuan A.;Yang P.-C.; Yu C.-J.; JIN-YUAN SHIH; Lee Y.-C.; Shun C.-T.; Yuan A.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:08Z |
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes
|
Sher Y.-P.;Jin-Yuan Shih;Yang P.-C.;Roffler S.R.;Chu Y.-W.;Wu C.-W.;Yu C.-L.;Peck K.; Sher Y.-P.; JIN-YUAN SHIH; Yang P.-C.; Roffler S.R.; Chu Y.-W.; Wu C.-W.; Yu C.-L.; Peck K. |
